Gamrekeli Alexander, Ramirez-Fragoso Fernando, Ghamarnejad Omid, Kardassis Dimitrios, Stöckle Felix, Custodis Florian, Stavrou Gregor A
Department for General, Visceral and Thoracic Surgery, Surgical Oncology, Klinikum Saarbrücken, Saarbrücken, Germany.
Department of Heart, Lung and Vascular Diseases, Intensive Care Medicine and Angiology, Klinikum Saarbrücken, Saarbrücken, Germany.
AME Case Rep. 2023 Sep 1;7:33. doi: 10.21037/acr-22-36. eCollection 2023.
Coronavirus disease [severe acute respiratory syndrome coronavirus disease 19 (SARS COVID-19)] has emerged as one of the most challenging diseases of recent decades. After the pandemic outbreak, our knowledge of the virus has expanded and developed, but we face a new wave of atypical complications that require special attention. In addition to the acute complications of COVID-19 infection, late complications of the disease are taking an increasingly important part in the management of affected patients, which are grouped under the collective term "Long COVID". In this work, we present our therapy strategy in three cases of pulmonary cavity as a late complication after COVID-19, as well as perform a literature review of published articles in this matter.
This study includes 3 cases of pulmonary cavities as a late COVID complication. Among them only one patient was vaccinated. The mean duration between the occurrence of Long COVID and SARS COVID-19 disease was 4 weeks in our patients. All patients underwent adequate medical therapy after Long COVID. However, due to the disease progression and significant elevated infections parameters, all patients underwent surgical therapy. One patient underwent uniportal video-assisted thoracoscopic surgery (VATS) lobectomy and decortication of the empyema, whereas we performed thoracotomy for other patients. All patients treated successfully and discharged shortly after the operation. Our literature review provides a total of 12 publications with only 50 patients. No patients received vaccination. The mean interval time between acute infection and the appearance of pulmonary cavities was about 4 weeks. The results showed that most patients were treated with conservative therapies. Only two patients were treated using invasive therapies. Both patients were successfully treated and recovered from the procedures.
This group of late complications COVID patients requires individualized treatment strategy. In the case of an underlying pulmonary cavities, depending on the findings, despite increased perioperative risks, very good results can be achieved by presentation to a specialized and experienced thoracic surgery center.
冠状病毒病[严重急性呼吸综合征冠状病毒病19(SARS-CoV-2)]已成为近几十年来最具挑战性的疾病之一。大流行爆发后,我们对该病毒的认识不断扩展和深入,但我们面临着一波需要特别关注的非典型并发症。除了COVID-19感染的急性并发症外,该疾病的晚期并发症在受影响患者的管理中发挥着越来越重要的作用,这些并发症被统称为“长新冠”。在这项工作中,我们展示了3例COVID-19后肺部空洞作为晚期并发症的治疗策略,并对该问题的已发表文章进行了文献综述。
本研究包括3例肺部空洞作为COVID晚期并发症的病例。其中只有1例患者接种了疫苗。在我们的患者中,长新冠出现与SARS-CoV-2疾病之间的平均持续时间为4周。所有患者在长新冠后均接受了充分的药物治疗。然而,由于疾病进展和感染参数显著升高,所有患者均接受了手术治疗。1例患者接受了单孔电视辅助胸腔镜手术(VATS)肺叶切除术和脓胸剥脱术,而其他患者我们进行了开胸手术。所有患者均成功治疗并在术后不久出院。我们的文献综述共提供了12篇出版物,仅涉及50例患者。没有患者接种疫苗。急性感染与肺部空洞出现之间的平均间隔时间约为4周。结果表明,大多数患者接受了保守治疗。只有2例患者接受了侵入性治疗。这2例患者均成功治疗并从手术中康复。
这组COVID晚期并发症患者需要个体化的治疗策略。对于潜在的肺部空洞情况,根据检查结果,尽管围手术期风险增加,但通过转诊至专业且经验丰富的胸外科中心,可以取得非常好的效果。